UBS: Sef aggregation 1.0

With trading of cleared OTC products set to migrate to a profusion of new platforms, dealers are planning to act as liquidity aggregators - and UBS has already taken a step in that direction. By Ramya Jaidev

Paul Hamill

It might seem an odd time for a dealer to launch a new over-the-counter derivatives trading platform, particularly in a market that looks likely to be subject to a clearing mandate. Rules on both sides of the Atlantic are still being crafted, but clearable products will need to be executed on a swap execution facility (Sef) in the US and an organised trading facility in Europe – and, in the US at least, dealers will not be able to own a Sef (see pages 45–48).

So what is UBS up to? It extended

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here